Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-Susceptible Pulmonary Tuberculosis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableStudy completedNCT00341601
What this trial is testing

Multi-Drug Resistant Tuberculosis in Korea

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 777
Post-approval studies (Phase 4)UnknownNCT02901288
What this trial is testing

Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Beijing Chest Hospital 3,900
Large-scale testing (Phase 3)Not Yet RecruitingNCT07076225
What this trial is testing

Ultra-Short Regimen for Elderly DS-TB

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 300
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Large-scale testing (Phase 3)UnknownNCT05575518
What this trial is testing

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Who this might be right for
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama 414
Early research (Phase 1)Study completedNCT02375698
What this trial is testing

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB

Who this might be right for
Tuberculosis
Aeras 22
Not applicableStudy completedNCT00834353
What this trial is testing

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

Who this might be right for
Pulmonary Tuberculosis
Maulana Azad Medical College
Not applicableUnknownNCT04264221
What this trial is testing

Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging

Who this might be right for
Pulmonary TB
Farman Ullah Khan 600
Testing effectiveness (Phase 2)Study completedNCT05455112
What this trial is testing

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Archivel Farma S.L. 41
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Not applicableNot Yet RecruitingNCT07668479
What this trial is testing

Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan

Who this might be right for
TuberculosisTuberculosis Infection, LatentTuberculosis, Pulmonary, Drug Sensitive
Public Union "Kazakhstan Association of Phthisiopulmonologists" 350
Not applicableStudy completedNCT03822156
What this trial is testing

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Who this might be right for
TuberculosisTuberculosis, PulmonaryCavity+5 more
University of Ulsan 500
Testing effectiveness (Phase 2)Looking for participantsNCT07525427
What this trial is testing

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Who this might be right for
Drug Susceptible Pulmonary Tuberculosis
Gates Medical Research Institute 150
Testing effectiveness (Phase 2)Study completedNCT04608955
What this trial is testing

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081

Who this might be right for
Pulmonary Tuberculosis
Shanghai Jiatan Pharmatech Co., Ltd 99
Testing effectiveness (Phase 2)UnknownNCT04768231
What this trial is testing

Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

Who this might be right for
Tuberculosis
Hospital Universitari Vall d'Hebron Research Institute 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07595042
What this trial is testing

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 900
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129629
What this trial is testing

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryDrug-Susceptible Pulmonary Tuberculosis
Shanghai Pulmonary Hospital, Shanghai, China 45
Large-scale testing (Phase 3)Study completedNCT00130247
What this trial is testing

Tuberculosis Treatment Shortening Trial

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 394
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Next Page